Drugs News and Research

RSS

QIAGEN receives first companion diagnostic approval in Japan

QIAGEN N.V. today announced that the Japanese Pharmaceuticals and Medical Device Agency has approved the therascreen EGFR RGQ PCR Kit to allow its use as a companion diagnostic with Pfizer's VIZIMPRO (dacomitinib) for EGFR gene mutation-positive, inoperable or recurrent non-small cell lung cancer.

17 Jan 2019

Researchers discover mechanism which drives leukemia cell growth

A mechanism which drives leukemia cell growth has been discovered by researchers at the University of Sussex, who believe their findings could help to inform new strategies when it comes to treating cancer.

17 Jan 2019

Yeast model may pave way for development of novel therapies for metabolic disorders

There are hundreds of metabolic disorders -- including phenylketonuria, tyrosinemia, maple syrup urine disease and homocystinuria.

17 Jan 2019

Researchers find new class of blood pressure-regulating peptides in vampire bat venom

Vampire bats could hold the key to new treatments for a range of serious medical problems, but researchers have hit a snag accessing the specimens needed to advance their work.

17 Jan 2019

Researchers develop artificial enzymatic pathway for synthesizing isoprenoids in E. coli

Researchers from North Carolina State University have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli.

17 Jan 2019

Opioid drugs often overprescribed to children for pain relief, say CHOP surgeons

Opioid drugs prescribed to children for pain relief after a typical pediatric orthopaedic procedure may be significantly overprescribed, according to a new study by researchers at Children's Hospital of Philadelphia (CHOP).

17 Jan 2019

Study pinpoints immune cells that could be key to tackling hypertension

Scientists have pinpointed cells in the immune system that could be key to tackling high blood pressure.

16 Jan 2019

FDA approves generic drug for treating focal seizures

The U.S. Food and Drug Administration approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex partial seizures, also called focal seizures, as an adjunctive therapy (given with another primary treatment) in patients 10 years and older who have responded inadequately to several alternative (refractory) treatments.

16 Jan 2019

The electronics industry sees money in your health

If the scores of personal health care devices at the Consumer Electronics Show last week are any indication, it's clear that the Apple Watch has kicked off a rush by high-tech companies to capitalize on people's worries about their health.

16 Jan 2019

How Patch Clamp Technology Can Benefit Ion Channel Research

Learn how patch clamp technology meets high-throughput to benefit ion channel research in this interview with Tim and James, Nanion.

From Nanion Technologies 16 Jan 2019

Researchers cultivate vascular organoids that perfectly mimic human blood vessels

For the first time, researchers have successfully cultivated “vascular organoids” in a petri dish that perfectly mimic real human blood vessels.

16 Jan 2019

Cobra Biologics announces appointment of Dr Darrell Sleep as Director of Innovation

Cobra Biologics, an international CDMO for biologics and pharmaceuticals, today announced the appointment of Dr Darrell Sleep as Director of Innovation.

From Charles River 16 Jan 2019

Breast cancer cells in mice coaxed to turn into harmless fat cells

As cancer cells respond to cues in their microenvironment, they can enter a highly plastic state in which they are susceptible to transdifferentiation into a different type of cell.

16 Jan 2019

Truncal mutations study suggests new direction in origins of cancer

Cancers most commonly arise because of a series of two to five mutations in different genes that combine to cause a tumor.

16 Jan 2019

Salk team uses new model to study health effects of AMP-activated protein kinase

The metabolic protein AMPK has been described as a kind of magic bullet for health. Studies in animal models have shown that compounds that activate the protein have health-promoting effects to reverse diabetes, improve cardiovascular health, treat mitochondrial disease--even extend life span.

16 Jan 2019

Researchers identify comprehensive guidelines for managing severe atopic dermatitis

A team of investigators from the University of Colorado College of Nursing at CU Anschutz Medical Campus and National Jewish Health has identified comprehensive guidelines for managing severe atopic dermatitis (AD), the most common form of eczema.

16 Jan 2019

Study proposes improvements in pharmacological study of cognitive function enhancers in schizophrenia

Schizophrenia is a serious, chronic mental disorder involving a series of symptoms. It is one of the leading causes of disability worldwide.

16 Jan 2019

Hypertension drug may improve effectiveness of ovarian cancer treatment

A new study from a Massachusetts General Hospital research team has found that the hypertension drug losartan, which targets the angiotensin signaling pathway, may improve the effectiveness of chemotherapy agents used to treat ovarian cancer

16 Jan 2019

Study suggests key role for glial cells in Parkinson's disease

A team of scientists led by Prof. Antonella Consiglio from the IDIBELL and the University of Barcelona, and Prof. Angel Raya from the Center of Regenerative Medicine of Barcelona have discovered that defective versions of human brain cells called astrocytes are linked to the buildup of a toxic protein that is one the hallmarks of Parkinson's disease.

16 Jan 2019

University of Nebraska to develop new drugs that prevent and counteract effects of radiation exposure

The U.S. Department of Defense has turned to the University of Nebraska to jumpstart the development of drug therapies to protect military service members from the effects of radiation exposure.

16 Jan 2019

Drugs News and Research

QIAGEN receives first companion diagnostic approval in Japan

Researchers discover mechanism which drives leukemia cell growth

Yeast model may pave way for development of novel therapies for metabolic disorders

Researchers find new class of blood pressure-regulating peptides in vampire bat venom

Researchers develop artificial enzymatic pathway for synthesizing isoprenoids in E. coli

Opioid drugs often overprescribed to children for pain relief, say CHOP surgeons

Study pinpoints immune cells that could be key to tackling hypertension

FDA approves generic drug for treating focal seizures

The electronics industry sees money in your health

How Patch Clamp Technology Can Benefit Ion Channel Research

Researchers cultivate vascular organoids that perfectly mimic human blood vessels

Cobra Biologics announces appointment of Dr Darrell Sleep as Director of Innovation

Breast cancer cells in mice coaxed to turn into harmless fat cells

Truncal mutations study suggests new direction in origins of cancer

Salk team uses new model to study health effects of AMP-activated protein kinase

Researchers identify comprehensive guidelines for managing severe atopic dermatitis

Study proposes improvements in pharmacological study of cognitive function enhancers in schizophrenia

Hypertension drug may improve effectiveness of ovarian cancer treatment

Study suggests key role for glial cells in Parkinson's disease

University of Nebraska to develop new drugs that prevent and counteract effects of radiation exposure

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News